SOLITOMAB Drug Record

  • SOLITOMAB chembl:CHEMBL2109264 Antineoplastic

    Alternate Names:

    MT110
    SOLITOMAB

    Drug Info:

    FDA Approval not approved
    Drug Class antibody
    Drug Indications antineoplastic agent
    (0 More Sources)

    Publications:

  • SOLITOMAB   EPCAM

    Interaction Score: 3.86

    Interaction Types & Directionality:
    antibody (inhibitory)

    Interaction Info:
    Notes
    Trial Name MT110
    Novel drug target Novel Target

    PMIDs:
    None found


    Sources:
    TALC TdgClinicalTrial

  • SOLITOMAB   CD3D

    Interaction Score: 2.21

    Interaction Types & Directionality:
    n/a

    Interaction Info:
    Trial Name MT110
    Novel drug target Established target

    PMIDs:
    None found


    Sources:
    TdgClinicalTrial

  • SOLITOMAB   CD3E

    Interaction Score: 1.55

    Interaction Types & Directionality:
    n/a

    Interaction Info:
    Novel drug target Established target
    Trial Name MT110

    PMIDs:
    None found


    Sources:
    TdgClinicalTrial

  • SOLITOMAB   CD3G

    Interaction Score: 1.19

    Interaction Types & Directionality:
    n/a

    Interaction Info:
    Trial Name MT110
    Novel drug target Established target

    PMIDs:
    None found


    Sources:
    TdgClinicalTrial

  • TdgClinicalTrial: MT110

    • Version: January-2014

    Alternate Names:

    Drug Info:
    Drug Indications antineoplastic agent
    Drug Class antibody
    FDA Approval not approved

    Publications:

  • TALC: MT110

    • Version: 12-May-2016

    Alternate Names:
    MT110 Primary Drug Name
    MT110 Drug Synonym

    Drug Info:

    Publications:

  • ChemblDrugs: chembl:CHEMBL2109264

    • Version: ChEMBL_27

    Alternate Names:

    Drug Info:

    Publications: